Granahan Investment Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-24,363
Closed -$7.93M 207
2024
Q1
$7.93M Sell
24,363
-16,439
-40% -$4.04M 0.28% 99
2023
Q4
$7.78M Buy
40,802
+11,050
+37% +$2.09M 0.26% 102
2023
Q3
$5.92M Buy
29,752
+6,961
+31% +$1.65M 0.21% 119
2023
Q2
$6.5M Sell
22,791
-6,690
-23% -$1.86M 0.2% 119
2023
Q1
$6.39M Buy
29,481
+4,488
+18% +$874K 0.19% 111
2022
Q4
$5.14M Buy
24,993
+5,340
+27% +$1.35M 0.16% 128
2022
Q3
$5.46M Sell
19,653
-2,374
-11% -$604K 0.18% 122
2022
Q2
$4.21M Buy
22,027
+10,570
+92% +$1.87M 0.14% 128
2022
Q1
$2.38M Buy
+11,457
New +$1.89M 0.06% 165

Other funds holding SWAV

Granahan Investment Management's SWAV Position: Q2 2024 in Review

Granahan Investment Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 24,363 shares — an estimated $7.93M sold.

Granahan Investment Management first reported a position in SWAV in Q1 2022 and held it in 9 quarters. The position peaked at $7.93M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Granahan Investment Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Granahan Investment Management sold 24,363 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $7.93M.
  • Granahan Investment Management first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2022 and held it in 9 quarters.
  • Granahan Investment Management's Shockwave Medical, Inc. Common Stock position peaked at $7.93M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Granahan Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.